US Senate Committee on Health, Education, Labor, & Pensions

Full Committee Hearing - FDA User Fee Agreements: Strengthening FDA and the Medical Products Industry for the Benefit of Patients


Thursday, March 29 2012, 10:00 AM


216 Hart Senate Office Building

Witnessesreturn to top

Panel I

  • Janet Woodcock, M.D. , Director, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
  • Jeffrey Shuren, M.D., J.D. , Director, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD

Panel II

  • David Wheadon, M.D. , Senior Vice President of Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, DC
  • Sara Radcliffe , Executive Vice President, Health, Biotechnology Industry Organization, Washington, DC
  • David R. Gaugh, R.Ph. , Vice President for Regulatory Affairs, Generic Pharmaceutical Association, Washington, DC
  • David Nexon, Ph.D. , Senior Executive Vice President, Advanced Medical Technology Association, Washington, DC
  • Allan Coukell, BScPharm , Director of Medical Programs, The Pew Charitable Trusts, Washington, DC